#9 – Rodolphe Barrangou - Catching up on the CRISPR craze

Genetic Engineering and Society Center

GES Colloquium - Tuesdays 12-1PM (via Zoom) NC State University | http://go.ncsu.edu/ges-colloquium
GES Mediasite - See videos, full abstracts, speaker bios, and slides https://go.ncsu.edu/ges-mediasite
Twitter - https://twitter.com/GESCenterNCSU

Catching up with the CRISPR craze: applications and implications of genome editing technologies

The advent of CRISPR-based technologies has revolutionized our ability to manipulate the genetic content of organisms across the tree of life, and democratized genome editing across the globe. Actually, genome editing technologies have been broadly deployed in academia and industry in the past 8 years, to manipulate the genomes of organisms relevant to medicine, biotechnology and agriculture. I will look back on the historical milestones that have paved the way for the CRISPR era, and discuss the diverse applications that have impacted and continue to shape the food and Ag supply chain, encompassing food fermentation, crops, livestock and forests. Given the business potential of this disruptive technology, it is important to also account for regulatory frameworks, public engagement, investment opportunities and competitive landscape implications.

Links & Resources

CRISPR Journal https://home.liebertpub.com/publications/the-crispr-journal/642

CRISPRcon (GES-led sessions on October 13 & 15 – Equity, Environment & Agriculture) https://crisprcon.org/crisprcon-2020/

Guest Speaker

Rodolphe Barrangou Ph.D. (Twitter @CRISPRlab and @CRISPRchef) is the T. R. Klaenhammer Distinguished Professor in Probiotics Research at NC State. Barrangou is focusing on the characterization of CRISPR-Cas systems, and their applications in bacteria. Rodolphe spent 9 years in R&D and M&A at DuPont. For his CRISPR work, Rodolphe received several international awards and has been elected into the National Academy of Sciences and the National Academy of Engineering. Dr. Barrangou is also the former Chairman of the Board of Caribou Biosciences, a co-founder of Intellia Therapeutics, Locus Biosciences, TreeCo, and CRISPR biotechnologies, and the Editor in Chief of the CRISPR Journal.

GES Center -  Integrating scientific knowledge & diverse public values in shaping the futures of biotechnology.

Find out more at https://ges-center-lectures-ncsu.pinecast.co